SENP6 Antikörper
-
- Target Alle SENP6 Antikörper anzeigen
- SENP6 (SUMO1/sentrin Specific Protease 6 (SENP6))
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser SENP6 Antikörper ist unkonjugiert
-
Applikation
- ELISA, Western Blotting (WB)
- Produktmerkmale
- Polyclonal Antibody
- Aufreinigung
- Antigen affinity purification
- Immunogen
- Synthetic peptide of human SENP6
- Isotyp
- IgG
- Top Product
- Discover our top product SENP6 Primärantikörper
-
-
- Applikationshinweise
- WB 1:500-1:2000, ELISA 1:5000-1:10000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1.14 mg/mL
- Buffer
- PBS with 0.05 % Sodium azide and 40 % Glycerol, pH 7.4
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- SENP6 (SUMO1/sentrin Specific Protease 6 (SENP6))
- Andere Bezeichnung
- SENP6 (SENP6 Produkte)
- Hintergrund
- Ubiquitin-like molecules (UBLs), such as SUMO1 (UBL1, MIM 601912), are structurally related to ubiquitin (MIM 191339) and can be ligated to target proteins in a similar manner as ubiquitin. However, covalent attachment of UBLs does not result in degradation of the modified proteins. SUMO1 modification is implicated in the targeting of RANGAP1 (MIM 602362) to the nuclear pore complex, as well as in stabilization of I-kappa-B-alpha (NFKBIA, MIM 164008) from degradation by the 26S proteasome.
- Molekulargewicht
-
Observed_MW: Refer to figures
Calculated_MW: 126 kDa
- UniProt
- Q9GZR1
-